Targeting treatment-resistant breast cancer stem cells with FKBPL and its peptide derivative, AD-01, via the CD44 pathway. (2013)

First Author: McClements L
Attributed to:  Confidence in Concept 2012 - Queen's University Belfast funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/1078-0432.ccr-13-0595

PubMed Identifier: 23741069

Publication URI: http://europepmc.org/abstract/MED/23741069

Type: Journal Article/Review

Volume: 19

Parent Publication: Clinical cancer research : an official journal of the American Association for Cancer Research

Issue: 14

ISSN: 1078-0432